Threonine Bioproduction Engineering Service

Threonine is an essential amino acid with high demand in the animal feed industry and the food sector. It is typically produced via microbial fermentation. However, industrial production is often limited by a low acid production rate in fermentation , meaning low Threonine yield which necessitates large fermentation volumes and increases processing costs. The high final cost of Threonine high cost limits feed application and margins, particularly in commodity markets like feed supplements. The synthesis pathway is severely constrained by end-product feedback inhibition and carbon flux diversion to competing pathways (e.g., Lysine, Methionine, Isoleucine).

CD Biosynsis offers a synthetic biology service focused on engineering Escherichia coli for high-titer Threonine production. Our core strategy involves modification of threonine synthase in Escherichia coli . Threonine is synthesized from Aspartate via Aspartate Semialdehyde and Homoserine. The final, irreversible step is catalyzed by Threonine Synthase (ThrC). We focus on modifying the upstream Aspartate kinase (ThrA) and Homoserine Dehydrogenase (ThrA) enzymes—both parts of the bi-functional ThrA—which are subject to Threonine feedback inhibition. We introduce mutations into these sites to create feedback-resistant variants (ThrA^mut). This is coupled with redirection of metabolic flux . We amplify the engineered ThrA^mut along with Homoserine Kinase (ThrB) and Threonine Synthase (ThrC). Simultaneously, we eliminate flux leakage by deleting or downregulating competing pathways for essential amino acids (e.g., LysA for Lysine or MetA for Methionine). This integrated approach aims to create a metabolic "superhighway" leading directly to Threonine, achieving high-concentration fermentation broth that dramatically lowers manufacturing costs, making the product viable for widespread feed application.

Pain Points

Achieving cost-competitive, high-yield Threonine production faces these key challenges:

• Low Acid Production Rate in Fermentation: The primary regulatory enzyme, Aspartate Kinase (ThrA), is highly sensitive to feedback inhibition by Threonine and Lysine, severely stalling the flux at high product concentrations.
• High Cost Limits Feed Application: Low titer fermentation broth requires extensive and costly downstream processing (evaporation, crystallization), pushing the final price too high for margin-sensitive feed applications.
• Metabolic Leakage: The Aspartate pathway is branched, and carbon flux is strongly diverted to the synthesis of Lysine, Methionine, and Isoleucine , leading to poor Threonine yield.
• Cofactor Limitation: The final steps of Threonine synthesis require cofactors (e.g., ATP and NADPH) that can become rate-limiting in high-density fermentation.

A successful solution must eliminate the feedback inhibition, redirect the carbon flow, and minimize cost through high yield.

Solutions

CD Biosynsis utilizes advanced metabolic engineering to optimize Threonine production in E. coli:

Modification of Threonine Synthase in E. coli

           

We perform rational design or directed evolution on ThrA to create a mutant (ThrA^mut) that is insensitive to feedback inhibition by Threonine and Lysine.

Redirection of Metabolic Flux

We use gene deletion (e.g., LysA deletion ) to block competing pathways (Lysine, Methionine) that divert the Aspartate precursor, forcing flux toward Threonine.

Overexpression of Entire Operon

We amplify the mutated ThrA^mut along with ThrB and ThrC to ensure all enzymes in the Threonine pathway are present at saturating levels.

Precursor and Cofactor Supply Optimization

We enhance the synthesis of the initial precursor, Aspartate, and co-express NADPH regeneration enzymes to ensure sustained production flux.

This systematic approach overcomes the primary regulation barriers and creates a robust, high-flux pathway for Threonine synthesis.

Advantages

Our Threonine engineering service is dedicated to pursuing the following production goals:

Significantly Increased Fermentation Titer

Removal of feedback inhibition and flux redirection allow for maximum product accumulation in the broth, solving the low acid production rate.

Market-Competitive Cost

High titer reduces purification costs, making Threonine economically viable for large-scale feed applications .

High L-Threonine Purity

Biosynthesis ensures the natural and desired L-Threonine isomer is produced with minimal by-products.

High Carbon Yield and Efficiency

Blocking competing pathways minimizes carbon loss, converting the feedstock into the final product with maximum efficiency .

Robust Fermentation Process Icon

The engineered E. coli strain is highly robust and suitable for scalable, high-cell-density fed-batch fermentation.

We provide a cost-effective, high-yield, and scalable manufacturing platform for L-Threonine.

Process

Our Threonine strain engineering service follows a rigorous, multi-stage research workflow:

• ThrA Mutagenesis: Identify the allosteric sites of ThrA that bind Threonine and Lysine and introduce mutations to abolish feedback inhibition .
• Operon Overexpression: Integrate and co-express the mutated ThrA^mut and native ThrB, ThrC at high copy numbers under a strong, regulated promoter.
• Competing Pathway Blockade: Use gene deletion (e.g., knock out LysA ) to prevent the synthesis of essential amino acids that share the Aspartate precursor.
• Precursor and Cofactor Supply: Enhance the initial steps of Aspartate synthesis from Oxaloacetate and co-express NADPH regeneration systems .
• Functional and Titer Assays: Validate the engineered strain in optimized fed-batch culture, measuring the final Threonine concentration and purity .
• Result Report Output: Compile a detailed Experimental Report including gene modification data, enzyme characterization, and fermentation metrics (final titer, yield, and purity) , supporting industrial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and pathway efficiency.

Explore the potential for a cost-competitive, high-purity Threonine supply. CD Biosynsis provides customized strain and pathway engineering solutions:

• Detailed Feedback Resistance and Flux Analysis Report , demonstrating the functional change in ThrA^mut and its impact on carbon flow.
• Consultation on optimized nutrient feeding and induction strategies for maximum Threonine production rates.
• Experimental reports include complete raw data on Threonine productivity (g/L/h) and final product yield (g/g glucose) , essential for cost-reduction analysis.